NCI-CPTC | GenomeWeb

NCI-CPTC

In particular, George Mason University researcher Emanuel Petricoin expressed concerns about the project's plan to use samples from different patient cohorts for its discovery and verification stages.

The project is part of the CPTC's Antibody Characterization Program, which aims to thoroughly characterize all monoclonal antibodies used in the initiative in an effort to minimize the experimental variability that has often hampered the use of affinity reagents in proteomics research.

The alliance aims to take proteomics into the clinical chemistry lab and to encourage proteomics researchers to adopt procedures and processes that are routinely practiced in clinical chemistry labs.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.